Aug 28, 2025 • GlobeNewswire
NEUTRAL
LeMaitre to Participate at Upcoming Investor Conferences in September
BURLINGTON, Mass., Aug. 28, 2025 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. ( Nasdaq:LMAT ) announced today that management will participate in four upcoming investor conferences.
Aug 27, 2025 • Zacks Commentary
BULLISH
Is LeMaitre ( LMAT ) a Solid Growth Stock? 3 Reasons to Think "Yes"
LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.
Aug 25, 2025 • Zacks Commentary
NEUTRAL
NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve
enVVeno Medical shares plunge after the FDA rejects its VenoValve PMA, citing insufficient trial data and safety concerns tied to the surgical procedure.
Aug 22, 2025 • Zacks Commentary
NEUTRAL
NVCR Stock Slips Despite PMA Application to Treat Pancreatic Cancer
NovoCure submits a PMA to the FDA for TTFields therapy in pancreatic cancer, aiming to expand its oncology reach.
Aug 11, 2025 • Zacks Commentary
BULLISH
LeMaitre ( LMAT ) is an Incredible Growth Stock: 3 Reasons Why
LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Aug 06, 2025 • Motley Fool
SOMEWHAT-BULLISH
LeMaitre ( LMAT ) Q2 Revenue Jumps 15%
LeMaitre Vascular ( NASDAQ:LMAT ) , a medical device company focused on vascular surgeons, reported its latest quarterly earnings after the bell on August 5, 2025. The company delivered GAAP results ahead of expectations, posting GAAP earnings per share of $0.60, above the anticipated $0.57 ( ...